tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

GB:0RNK Stock Latest News

Inventiva receives $10M milestone payment from Chia Tai-Tianqing Pharmaceutical
The FlyInventiva receives $10M milestone payment from Chia Tai-Tianqing Pharmaceutical
10h ago
IVA
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
PremiumRatings
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
1M ago
IVA
Inventiva describes share repurchase covered by Kepler Chevreux agreement
PremiumThe Fly
Inventiva describes share repurchase covered by Kepler Chevreux agreement
2M ago
IVA
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
PremiumRatings
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
3M ago
IVA
Inventiva price target lowered to $9 from $12 at Guggenheim
PremiumThe Fly
Inventiva price target lowered to $9 from $12 at Guggenheim
3M ago
IVA
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright
PremiumThe FlyInventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright
3M ago
IVA
Inventiva’s Strategic Advancements and Financial Strength Bolster Buy Rating
Premium
Ratings
Inventiva’s Strategic Advancements and Financial Strength Bolster Buy Rating
3M ago
IVA
Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
Premium
Ratings
Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
3M ago
IVA
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
PremiumRatings
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
3M ago
IVA
Inventiva SA Earnings Call: Positive Outlook Amid Challenges
PremiumCompany Announcements
Inventiva SA Earnings Call: Positive Outlook Amid Challenges
3M ago
Inventiva’s Strategic Positioning and Clinical Progress Drive Buy Rating Amid Promising MASH Therapy Developments
PremiumRatings
Inventiva’s Strategic Positioning and Clinical Progress Drive Buy Rating Amid Promising MASH Therapy Developments
3M ago
IVA
Promising Developments and Financial Outlook Propel Inventiva’s Phase III NATiV3 Trial Forward
PremiumRatings
Promising Developments and Financial Outlook Propel Inventiva’s Phase III NATiV3 Trial Forward
3M ago
IVA
Inventiva publishes lanifibranor results in Biomedicine & Pharmacotherapy
PremiumThe FlyInventiva publishes lanifibranor results in Biomedicine & Pharmacotherapy
4M ago
IVA
Inventiva initiated with a Buy at TD Cowen
Premium
The Fly
Inventiva initiated with a Buy at TD Cowen
5M ago
IVA
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
Premium
Ratings
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
5M ago
IVA
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
PremiumThe Fly
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
5M ago
IVA
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
PremiumRatings
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
5M ago
IVA
Inventiva publishes lanifibranor trial results in Journal of Hepatology
PremiumThe Fly
Inventiva publishes lanifibranor trial results in Journal of Hepatology
5M ago
IVA
Inventiva price target lowered to $17 from $20 at Stifel
PremiumThe Fly
Inventiva price target lowered to $17 from $20 at Stifel
8M ago
IVA
Inventiva reports revenues for irst nine months FY24 EUR 1.3M
PremiumThe FlyInventiva reports revenues for irst nine months FY24 EUR 1.3M
8M ago
IVA
Inventiva initiated with a Neutral at UBS
Premium
The Fly
Inventiva initiated with a Neutral at UBS
8M ago
IVA
Inventiva announces DMC recommendation to continue NATiV3 trial as is
Premium
The Fly
Inventiva announces DMC recommendation to continue NATiV3 trial as is
8M ago
IVA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >